Symbol Therapeutics

Modified Protein for Treatment of Autoimmune Diseases

Health Tech & Life Sciences

Non Active, Nov 2025 ceased to operate

Seed Ness Ziona Founded 2021

Total raised

$3.0M

Last: Seed 2022-09

Stage

Seed

Founded

2021

Headcount

Ness Ziona

Sector

Health Tech & Life Sciences

About

Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein, which is a modified form of the endogenous Semaphorin3A, for the treatment of systemic lupus erythematosus and other autoimmune diseases. Its proprietary modified protein is able to activate anti-inflammatory regulatory mechanisms and thereby restore normal immune homeostasis.

Funding history · 1 round · $3.0M total

2022-09

Seed $3.0M

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsMolecules

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Name	Symbol Therapeutics
Slug	symbol-therapeutics
Type	Israeli Startup
Founded	2021
HQ city	Ness Ziona
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Seed
Public stage	Seed
Total raised (USD)	3,000,000
Last round	Seed (2022-09)
Israeli Companies Registrar	516495587

Name	Role	LinkedIn
Adi Sagiv
Zahava Vadasz
Elias Toubi

Symbol Therapeutics

About

Funding history · 1 round · $3.0M total

Sectors & technology

Tags